Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $313.1M
Liabilities Breakdown FY2020
Total Liabilities: $262.5M
Asset Breakdown
Total Assets: $313.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $85.9M | 27.4% |
| Accounts Receivable | $12.9M | 4.1% |
| Inventory | $2.6M | 0.8% |
| Property, Plant & Equipment | $2.2M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $209.4M | 66.9% |
Liabilities Breakdown
Total Liabilities: $262.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.5M | 1.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $258.1M | 98.3% |